The Discounted Cash Flow (DCF) valuation of Bio Rad Laboratories Inc (BIO) is 368.69 USD. With the latest stock price at 251.56 USD, the upside of Bio Rad Laboratories Inc based on DCF is 46.6%.
Based on the latest price of 251.56 USD and our DCF valuation, Bio Rad Laboratories Inc (BIO) is a buy. buying BIO stocks now will result in a potential gain of 46.6%.
| Range | Selected | |
| WACC / Discount Rate | 6.9% - 9.2% | 8.1% |
| Long-term Growth Rate | 0.5% - 1.5% | 1.0% |
| Fair Price | 301.22 - 476.70 | 368.69 |
| Upside | 19.7% - 89.5% | 46.6% |